DLB Stock Earnings Estimates Increased by Zacks Research

Dolby Laboratories (NYSE:DLB – Free Report) – Investment analysts at Zacks Research lifted their Q3 2027 EPS estimates for shares of Dolby Laboratories in a report issued on Monday, November 16th. Zacks Research analyst Team now anticipates that the electronics maker will post earnings of $0.58 per share for the quarter, up from their previous estimate of $0.57. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Dolby Laboratories’ current full-year earnings is $3.36 per share. Zacks Research also issued estimates for Dolby Laboratories’ FY2027 earnings at $3.20 EPS, Q1 2028 earnings at $0.66 EPS, Q2 2028 earnings at $0.92 EPS, Q3 2028 earnings at $0.87 EPS and FY2028 earnings at $3.40 EPS.

Other equities research analysts have also recently issued research reports about the company. Rosenblatt Securities cut their target price on Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday. Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Finally, Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and an average target price of $85.00.

View Our Latest Report on Dolby Laboratories

Dolby Laboratories Price Performance

DLB stock opened at $56.88 on Tuesday. The stock has a market capitalization of $5.33 billion, a P/E ratio of 21.07 and a beta of 0.79. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $69.95. The business has a 50-day moving average of $60.80 and a 200-day moving average of $59.37.

Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its earnings results on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.05. The firm had revenue of $373.54 million during the quarter, compared to analyst estimates of $372.76 million. Dolby Laboratories had a net margin of 18.14% and a return on equity of 11.78%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.99 EPS. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS.

Dolby Laboratories declared that its Board of Directors has approved a share repurchase plan on Thursday, July 30th that permits the company to repurchase $350 million in outstanding shares. This repurchase authorization permits the electronics maker to buy up to 7% of its stock through open market purchases. Share repurchase plans are usually an indication that the company’s management believes its stock is undervalued.

Dolby Laboratories Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 9th. Stockholders of record on Tuesday, December 1st will be paid a dividend of $0.39 per share. The ex-dividend date is Tuesday, December 1st. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.7%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.36. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.

Insider Activity

In related news, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the sale, the chief accounting officer owned 34,453 shares of the company’s stock, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP John Couling sold 7,667 shares of the company’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the sale, the senior vice president owned 166,803 shares in the company, valued at $9,804,680.34. The trade was a 4.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 16,517 shares of company stock valued at $995,963 in the last 90 days. 37.93% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Dolby Laboratories

Institutional investors and hedge funds have recently made changes to their positions in the stock. Fulcrum Asset Management LLP grew its stake in shares of Dolby Laboratories by 733.7% in the third quarter. Fulcrum Asset Management LLP now owns 1,434 shares of the electronics maker’s stock valued at $83,000 after buying an additional 1,262 shares in the last quarter. Nisa Investment Advisors LLC raised its position in Dolby Laboratories by 130.1% during the third quarter. Nisa Investment Advisors LLC now owns 1,452 shares of the electronics maker’s stock worth $85,000 after acquiring an additional 821 shares in the last quarter. Nykredit A S acquired a new stake in Dolby Laboratories in the second quarter valued at $101,000. Hantz Financial Services Inc. lifted its stake in Dolby Laboratories by 86.0% in the third quarter. Hantz Financial Services Inc. now owns 2,557 shares of the electronics maker’s stock valued at $150,000 after acquiring an additional 1,182 shares during the last quarter. Finally, Greenwich Wealth Management LLC acquired a new stake in Dolby Laboratories in the third quarter valued at $217,000. Institutional investors own 58.56% of the company’s stock.

Key Stories Impacting Dolby Laboratories

These are some of the DLB stories that stood out recently:

  • Positive Sentiment: Fiscal Q4 revenue rose 21.7% year over year to $373.5 million, slightly ahead of estimates, while EPS of $1.25 topped the $1.20 consensus. Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2026 Financial Results
  • Positive Sentiment: Dolby raised its quarterly dividend 8.3% to $0.39 per share, equivalent to $1.56 annually. The company also highlighted that advanced audio and imaging patents generated more than half of licensing revenue, and its Video Distribution Patent Program grew to 47 licensors. Dolby: 3 Key Takeaways for Long-Term Investors
  • Negative Sentiment: Forward guidance is the key concern: fiscal Q1 revenue is forecast at $285 million–$305 million, well below the $358.3 million analyst consensus. Fiscal 2027 revenue guidance of about $1.4 billion also trails the $1.5 billion consensus, raising concerns about near-term growth and macroeconomic pressures. Dolby Laboratories and Other Stocks Moving Lower

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.